Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Thall

Showing results (91-100 of 190) with videos related to

Pageof 19
Sort By:
Biometrics|August 21, 2013
Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimesPeter F Thall, Hoang Q Nguyen, Thomas M Braun, et al.
Statistics in Medicine|April 20, 2026
BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing ChangesCheng-Han Yang, Peter F Thall, David Marin, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|June 16, 2023
A Bayesian feature allocation model for identifying cell subpopulations using CyTOF dataArthur Lui, Juhee Lee, Peter F Thall, et al.
Journal of the American Statistical Association|September 26, 2017
Robust treatment comparison based on utilities of semi-competing risks in non-small-cell lung cancerThomas A Murray, Peter F Thall, Ying Yuan, et al.
Statistics in Medicine|July 19, 2005
Continuous Bayesian adaptive randomization based on event times with covariatesYing Kuen Cheung, Lurdes Y T Inoue, J Kyle Wathen, et al.
Biometrics|July 24, 2025
Precision generalized phase I-II designsSaijun Zhao, Peter F Thall, Ying Yuan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 27, 2016
Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancerLiru He, Andrew Chapple, Zhongxing Liao, et al.
Bayesian Analysis|October 24, 2022
Robust Adaptive Incorporation of Historical Control Data in a Randomized Trial of External Cooling to Treat Septic ShockThomas A Murray, Peter F Thall, Frederique Schortgen, et al.
Clinical Trials (London, England)|April 4, 2024
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project OptimusPeter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture systemPeter H Shaw, Devin Gilligan, Xue-Mei Wang, et al.
Pageof 19

Showing results (91-100 of 190) with videos related to

Sort By:
Pageof 19
Biometrics|August 21, 2013
Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimesPeter F Thall, Hoang Q Nguyen, Thomas M Braun, et al.
Statistics in Medicine|April 20, 2026
BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing ChangesCheng-Han Yang, Peter F Thall, David Marin, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|June 16, 2023
A Bayesian feature allocation model for identifying cell subpopulations using CyTOF dataArthur Lui, Juhee Lee, Peter F Thall, et al.
Journal of the American Statistical Association|September 26, 2017
Robust treatment comparison based on utilities of semi-competing risks in non-small-cell lung cancerThomas A Murray, Peter F Thall, Ying Yuan, et al.
Statistics in Medicine|July 19, 2005
Continuous Bayesian adaptive randomization based on event times with covariatesYing Kuen Cheung, Lurdes Y T Inoue, J Kyle Wathen, et al.
Biometrics|July 24, 2025
Precision generalized phase I-II designsSaijun Zhao, Peter F Thall, Ying Yuan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 27, 2016
Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancerLiru He, Andrew Chapple, Zhongxing Liao, et al.
Bayesian Analysis|October 24, 2022
Robust Adaptive Incorporation of Historical Control Data in a Randomized Trial of External Cooling to Treat Septic ShockThomas A Murray, Peter F Thall, Frederique Schortgen, et al.
Clinical Trials (London, England)|April 4, 2024
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project OptimusPeter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture systemPeter H Shaw, Devin Gilligan, Xue-Mei Wang, et al.
Pageof 19